sanyal-biotechnology | Media Room | PressRelease.com

Tagged sanyal-biotechnology

Gencia, LLC Will Present Preclinical Results in the DIAMOND Mice Supporting the Therapeutic Potential of Its Lead Mitochondrial Therapeutic, GEN-3026, to Treat NASH at the International Liver CongressTM, Paris, France, April 11-15 2018

Press Release Mar 7, 2018

Gencia, LLC Will Present Preclinical Results in the DIAMOND Mice Supporting the Therapeutic Potential of Its Lead Mitochondrial Therapeutic, GEN-3026, to Treat NASH at the International Liver CongressTM, Paris, France, April 11-15 2018

Results Demonstrate that GEN-3026 Successfully Met the Primary Study Endpoint of Treating and Preventing Progression of NASH Read More

First
Prev

1

Next
Last